EXTON, Pa., Nov. 1, 2018 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, today
announced that its Management Team will present an overview of the
Company's business at two investor conferences in November.
Management will present at the Stephens Investment Conference in
New York, New York on Wednesday, November 7, 2018, and the Jefferies
2018 London Healthcare Conference in London, United Kingdom on Thursday, November 15, 2018.
A live audio webcast and the presentation will be accessible
from the Company's website at www.westpharma.com/en/investors.
About West
West Pharmaceutical Services, Inc. is a
leading manufacturer of packaging components and delivery systems
for injectable drugs and healthcare products. Working by the side
of its customers from concept to patient, West creates products
that promote the efficiency, reliability and safety of the world's
pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its
customers from locations in North and South America, Europe, Asia
and Australia. West's 2017 net
sales of $1.6 billion reflect the
daily use of approximately 112 million of its components and
devices, which are designed to improve the delivery of healthcare
to patients around the world.
Trademarks and registered trademarks are the property of West
Pharmaceutical Services, Inc. in the
United States and other jurisdictions, unless noted
otherwise.
Investor
Contact:
|
Media
Contact:
|
Quintin
Lai
|
Emily
Denney
|
Vice President,
Investor Relations
|
Vice President,
Global Communications
|
+1-610-594-3318
|
+1-610-594-3035
|
Quintin.Lai@westpharma.com
|
Emily.Denney@westpharma.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/west-announces-participation-in-upcoming-november-investor-conferences-300741614.html
SOURCE West Pharmaceutical Services, Inc.